123 related articles for article (PubMed ID: 37078565)
1. Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value.
Lin Y; Zhang B; Su L; Wei J; Chen Z; Wu M
Biotechnol Genet Eng Rev; 2023 Apr; ():1-12. PubMed ID: 37078565
[TBL] [Abstract][Full Text] [Related]
2. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Ding XZ; Zhang SQ; Deng XL; Qiang JH
Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
6. Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.
Zhang X; Guo H; Bao Y; Yu H; Xie D; Wang X
Oncol Lett; 2019 Nov; 18(5):5197-5204. PubMed ID: 31612030
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
Fu X; Tian Y; Kuang W; Wen S; Guo W
Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
[TBL] [Abstract][Full Text] [Related]
8. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Zhao Z; Liang S; Sun F
Front Oncol; 2020; 10():1172. PubMed ID: 32850336
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
Zhang L; He X; Jin T; Gang L; Jin Z
Biomed Pharmacother; 2017 Dec; 96():884-891. PubMed ID: 29145165
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
[TBL] [Abstract][Full Text] [Related]
13. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
Wu C; Lin W; Fu F
Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
[TBL] [Abstract][Full Text] [Related]
15. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
Xue C; Lv L; Jiang J; Li L
Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
[TBL] [Abstract][Full Text] [Related]
16. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
Wu SB; Wang HQ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
Zhang N; Meng X; Mei L; Zhao C; Chen W
J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
